Back to User profile » Dr Dennis Doherty
Papers published by Dr Dennis Doherty:
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/-7TXksfo2BY/1.jpg)
Yawn BP, Mintz ML, Doherty DE
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:289-299
Published Date: 12 February 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial
Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno C, Knorr B, Shekar T, Banerjee S, Staudinger H
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:43-55
Published Date: 3 February 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
Doherty DE, Tashkin DP, Kerwin E, Knorr BA, Shekar T, Banerjee S, Staudinger H
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:57-71
Published Date: 3 February 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials
Tashkin DP, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T, Gates D, Staudinger H
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:73-86
Published Date: 3 February 2012